What is the clinical significance of a Hollenhorst plaque?

Clinical Significance of Hollenhorst Plaque

A Hollenhorst plaque is a marker of systemic atherosclerotic disease that warrants a non-urgent but comprehensive cardiovascular workup, including carotid imaging, regardless of whether the patient has visual symptoms. 1

What It Represents

Hollenhorst plaques are platelet-fibrin-cholesterol emboli visible on fundoscopy, typically appearing as bright, refractile yellow-orange crystals lodged at retinal arterial bifurcations. These emboli most commonly originate from:

• Carotid arteries (most common source)
• Heart valves
• Aortic arch 1

The presence of these plaques indicates active atherosclerotic disease with embolic potential, even when discovered incidentally without visual symptoms.

Stroke Risk Assessment

The stroke risk associated with Hollenhorst plaques varies significantly based on clinical context:

Asymptomatic plaques carry a moderate cerebrovascular risk:

• Approximately 12% of patients develop stroke, TIA, or death from major carotid events during follow-up (6-86 months) 2
• Historical stroke/TIA rate of 17.8% at presentation (>6 months prior) 2
• However, one study found these patients have lower stroke risk compared to those with amaurosis fugax, with 94% survival at 36 months and no strokes during follow-up 3

Critical distinction: Patients with amaurosis fugax have significantly higher rates of severe carotid stenosis (53%) compared to those with asymptomatic Hollenhorst plaques (9%) 4. This explains why asymptomatic plaques alone may not predict imminent stroke as strongly as symptomatic embolic events.

Required Workup

All patients with Hollenhorst plaques—symptomatic or asymptomatic—require:

1. Carotid duplex ultrasound 5, 4

   • Even asymptomatic patients warrant imaging
   • Presence of carotid bruit increases likelihood of significant stenosis (>69% stenosis in 37% with bruit vs. 4.3% without) 5

2. Cardiovascular risk factor optimization 1, 2:

   • Smoking cessation
   • Blood pressure control
   • Diabetes management
   • Lipid management with statins
   • Antiplatelet therapy

3. Systemic atherosclerotic disease evaluation 1

   • Assessment for coronary artery disease
   • Evaluation of other vascular territories

Carotid Stenosis Findings

The degree of carotid stenosis in patients with Hollenhorst plaques is typically modest:

• 68% have <30% stenosis
• 22% have 30-60% stenosis
• Only 8% have >60% stenosis 3

However, symptomatic patients are more likely to have severe stenosis (>69%) compared to asymptomatic patients (25% vs. 9.2%) 5.

Intervention Thresholds

Currently, there is no evidence supporting carotid endarterectomy or stenting based solely on the presence of Hollenhorst plaques 2. Revascularization decisions should follow standard criteria for carotid stenosis severity and symptom status, not the presence of retinal emboli alone.

The emerging evidence suggests that even "non-stenotic" carotid plaques with high-risk features may be embolic sources 6, but intervention thresholds remain under investigation.

Monitoring Requirements

Ophthalmologic surveillance for complications:

• Risk of iris neovascularization (20% in complete retinal artery occlusions, typically 30-60 days post-event) 1
• Neovascular glaucoma risk
• Serial examinations for progression

Vascular surveillance:

• Serial carotid imaging has not shown significant progression in most patients 3
• Focus on medical optimization rather than expectant surgical intervention

Common Pitfalls

• Do not dismiss asymptomatic plaques: They still indicate systemic atherosclerotic disease requiring workup 5
• Do not assume high-grade stenosis: Most patients have <30% stenosis 3
• Do not rush to intervention: The presence of plaques alone does not justify carotid surgery 2
• Do not forget systemic evaluation: These patients need comprehensive cardiovascular risk assessment, not just carotid imaging 1, 2